EFPIA welcomes Member States sharing experience on new models for patient access
02.10.15
He announced the creation of a new working group to look at "new financial models". EFPIA and its members are keen to engage in the debate and to partner with payers to deliver outcomes driven, sustainable healthcare. This requires a shift in focus from immediate budget impact to long-term, sustainable improvements in patient outcomes and increased efficiency.
EFPIA member companies are showing their commitment to find solutions to ensure access to medicines in practice. There are hundreds of access schemes, so called "managed entry agreements" across Europe, agreed between EFPIA member companies and member state payers. There are numerous examples such as EFPIA' s member association in Belgium, pharma.be's agreement with the Belgian Minister of Health to enter managed entry agreements for all new products and to track performance through electronic health records. In Latvia, EFPIA and its national association SIPPAhave agreed with the Minister of Health, to develop a new access and payment model for oncology drugs, enabling the evaluation and payment for combination use of new cancer medicines. These are just two examples from a rapidly evolving field. EFPIA supports any collaboration that enhances patient access to medicines, builds transparency of research pipelines and builds capacity for managed entry agreements and new payment models.